The FY2025 (Dec) proxy of Allogene Therapeutics names 20 peer companies for pay. Pay versus performance data of Allogene Therapeutics for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Vir Biotechnology | ||
| Nurix Therapeutics | ||
| Beam Therapeutics | ||
| Agios Pharmaceuticals | ||
| Precigen | ||
| Cullinan Therapeutics | ||
| Lyell Immunopharma | ||
| Replimune Group | ||
| Nkarta | ||
| C4 Therapeutics | ||
| Editas Medicine | ||
| Fate Therapeutics | ||
| CARGO Therapeutics, Inc. | Not disclosed | Not disclosed |
| Cabaletta Bio | Not disclosed | Not disclosed |
| Caribou Biosciences | Not disclosed | Not disclosed |
| Foghorn Therapeutics | Not disclosed | Not disclosed |
| IGM Biosciences, Inc. | Not disclosed | Not disclosed |
| Sana Biotechnology | Not disclosed | Not disclosed |
| Xencor | Not disclosed | Not disclosed |
| iTeos Therapeutics, Inc. | Not disclosed | Not disclosed |
20 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.